Showing 193 results
- Pulse Update /
- Pulse Update /
- Pulse Update /
- Featured News /
Novartis announces the company’s fourth quarter and 2022 full year financial results.
- Statement /
- Statement /
- Statement /
- Statement /
- Statement /
- Featured News /
Cell Therapies Pty Ltd has become the first approved CAR-T commercial manufacturing site in Australia, providing potentially faster access to CAR-T therapies to eligible patients in the region with life-threatening blood cancers.
Novartis global commercial CAR-T manufacturing footprint now spans four continents, bringing these transformative therapies closer to patients and healthcare professionals around the world.
Pagination
- ‹ Previous page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- …
- 20
- › Next page